Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep725 | Pituitary and Neuroendocrinology | ECE2020

One year of growth hormone therapy in spanish adults with prader-willi syndrome (PWS) improves body composition without changes in bone mineral density

Casamitjana Laia , Giménez-Palop Olga , Pareja Rocío , Corripio Raquel , León Josep , Caixàs Assumpta

Introduction: PWS is the most common cause of genetic obesity. These patients have an abnormal body composition with increased amounts of fat mass (FM), reduced lean body mass (LBM) and diminished bone mineral density (BMD), all similar to patients with growth hormone deficiency (GHD).The abnormal body composition has been described due to impairment of the activity of GH-IGF system and to hypogonadism. Studies ongrowth hormone (GH) treatment in PWS adults from other European ...

ea0070ep215 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Decalogue of venipucture process of an experienced nurse in adult patients with prader willi syndrome

Pareja Rocío , Giménez-Palop Olga , Casamitjana Laia , Couto Yolanda , Luengo Marina , Rigla Mercedes , Caixàs Assumpta

Background: Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder characterized by marked hyperphagia and morbid obesity, together with hormone deficiencies, abnormal behaviour in relation to food (obsessive thinking, food foraging, stealing, etc.). Veins in patients with PWS are difficult to find due to obesity and probably to generalised hypotonia including venous tone. Since treating a patient with PWS often requires the acquisition of blood samples, an exper...